Latest filing published 23 Mar 2023 for ImmunoPrecise Antibodies Ltd., €445.
This profile gathers the share dealings of James Kuo in ImmunoPrecise Antibodies Ltd. In total, 6 filings cover trades dated from 29 December 2016 to 17 March 2023.
The open-market side counts 2 purchases for €1,114 alongside 1 sale for €22k. Netting one side against the other leaves €21k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises. Since January 2023: 2 purchases and no sales on the market.
Most recently, on 23 March 2023, the filings show an open-market purchase worth €445 in ImmunoPrecise Antibodies Ltd. The median gap between a trade and its publication by SEDI is 6 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations